Politics ❯Government Policy ❯Trade Policy ❯Tariffs

Pharmaceutical Tariffs

Pharmaceuticals Exempt from Trump's Tariffs, Industry Faces Uncertainty

Global Markets Plunge as Trump’s Tariffs Trigger Economic Unrest

Markets React to Trump's Tariff Plans with Volatility and Optimism

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion